Claudia-35 2 mg - 0,035 mg coat. tabl.

Country: Belġju

Lingwa: Ingliż

Sors: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ixtrih issa

Ingredjent attiv:

Ethinylestradiol 0,035 mg; Cyproterone acetate 2 mg

Disponibbli minn:

Sandoz SA-NV

Kodiċi ATC:

G03HB01

INN (Isem Internazzjonali):

Cyproterone acetate; Ethinylestradiol

Dożaġġ:

2 mg - 0,035 mg

Għamla farmaċewtika:

Coated tablet

Kompożizzjoni:

Cyproterone acetate 2 mg; Ethinylestradiol 35 µg

Rotta amministrattiva:

Oral use

Żona terapewtika:

Cyproterone and Estrogen

Sommarju tal-prodott:

CTI code: 265255-01 - Pack size: 21 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 265255-03 - Pack size: 6 x 21 - Commercialisation status: YES - FMD code: 07613421010836 - CNK code: 2164929 - Delivery mode: Medical prescription; CTI code: 265255-02 - Pack size: 3 x 21 - Commercialisation status: YES - FMD code: 07613421010843 - CNK code: 2157352 - Delivery mode: Medical prescription; CTI code: 265264-01 - Pack size: 21 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 265264-04 - Pack size: 13 x 21 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 265264-03 - Pack size: 6 x 21 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 265264-02 - Pack size: 3 x 21 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 265255-04 - Pack size: 13 x 21 - Commercialisation status: NO - CNK code: 2614857 - Delivery mode: Medical prescription

L-istatus ta 'awtorizzazzjoni:

Commercialised: No

Data ta 'l-awtorizzazzjoni:

2004-08-16

Dokumenti f'lingwi oħra

Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Ġermaniż 17-01-2023
MMR MMR Ġermaniż 01-07-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Franċiż 17-01-2023
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Franċiż 17-01-2023
RMP RMP Franċiż 10-11-2022
DHPC DHPC Franċiż 23-02-2023
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Olandiż 17-01-2023
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Olandiż 17-01-2023
RMP RMP Olandiż 10-11-2022
DHPC DHPC Olandiż 23-02-2023